Phathom Pharmaceuticals PHAT Stock Analysis 204 Loss Key Levels 20260513 Huntington HBAN Q1 2026 Results Fall Short EPS 025 Revenue NA Traders Express Skepticism Over GameStops Potential eBay Acquisition Barclays Sees Positive Trends for Home Depot as Fundamentals Strengthen Select Medical Holdings SEM Holds Steady Near Key Support After Modest Uptick MCN Holds Steady at 583 as Premium Income Fund Navigates Narrow Range Energizer Holdings ENR Surges 5 Breaking Above Key Resistance Zone Scinai Immunotherapeutics SCNI Declines 725 Eyes Key Support at 043